Philip A. Kalra

Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Iain C. Macdougall, Andreas J. Bircher, Kai‐Uwe Eckardt et al. · Kidney International · 2016 · 468 citations · Full text

Intravenous Iron in Patients Undergoing Maintenance Hemodialysis

Iain C. Macdougall, Claire White, Stefan D. Anker et al. · New England Journal of Medicine · 2018 · 464 citations · Full text

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Paul R. Kalra, John G.F. Cleland, Mark C. Petrie et al. · The Lancet · 2022 · 344 citations · Full text

Heart Failure, Intravenous Ferric Derisomaltose, Iron Metabolism +3

Atherosclerotic renovascular disease in United States patients aged 67 years or older: Risk factors, revascularization, and prognosis

Philip A. Kalra, Haifeng Guo, Annamaria T. Kausz et al. · Kidney International · 2005 · 326 citations

Hypertension, Vascular Disease, Cardiovascular Epidemiology +12

Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: The Atherosclerosis Risk in Communities (ARIC) Study

Robert N. Foley, Allan J. Collins, Areef Ishani et al. · American Heart Journal · 2008 · 275 citations

Vascular Disease, Atherosclerosis Risk, Cardiovascular Epidemiology +9